Biotech PR

Biotech PR is the practice of earning media coverage and credibility for life sciences companies — getting CEOs and scientists quoted in trade and business press, booked on podcasts, published in industry outlets, and accurately represented in AI-generated answers about their therapeutic areas. It combines media relations, scientific thought leadership, awards, and generative engine optimization (GEO), with the discipline that regulated, data-driven communications demand.

The fastest paths are answering journalist requests from science and biotech reporters on HARO, Connectively, X, and LinkedIn; placing executive bylines on trial design and the funding environment; joining life sciences podcasts; and offering measured commentary on FDA decisions and major readouts. Featured surfaces all of these in one chat and drafts responses that respect forward-looking-statement guardrails.

PR budgets vary widely with scope, goals, and the partners involved. Featured itself is free to start, with paid plans at $39/month (Lite) and $79/month (Pro, billed annually) — and every plan includes every capability: journalist requests, podcasts, bylines, awards, monitoring, and GEO tracking. Many life sciences companies and their agency partners run Featured alongside their existing PR programs.

GEO is the practice of improving how AI assistants like ChatGPT, Claude, Perplexity, and Gemini describe your company. When investors, partners, or patients research your therapeutic area, those answers are built from press coverage, publications, and structured content across the web — and inaccuracies about a pipeline are costly. Featured audits how AI systems characterize your programs and tracks changes over time.

AI engines cite brands that appear consistently across credible sources: trade coverage, peer-reviewed publications, conference presentations, analyst notes, and podcasts. That means earned media is the input to AI visibility. Run a GEO audit to see where you stand today, then close the gap with journalist requests, bylines, and podcast placements — and measure weekly.

Yes. Featured owns and operates HARO (Help a Reporter Out) and Connectively, and an expert is connected with a publisher every 6 seconds across the platforms. Life sciences topics — drug development, clinical trials, gene therapy, AI in discovery — are among the most frequently requested source categories, and Featured matches you to relevant queries automatically.

Ask Featured to build a media list of reporters who have covered your topic in the last 90 days — for example, “journalists writing about obesity drug development.” You'll get names, outlets, beats, and recent headlines, so every pitch references the reporter's actual work instead of going in cold.

Journalist-request responses can land placements within days, since reporters are on deadline. Bylines and podcasts typically take 2–8 weeks from pitch to publish, plus scientific and legal review on your side. AI visibility moves more slowly: expect roughly 1–3 months for new coverage to shift how AI assistants answer, which is why continuous tracking beats one-off audits.

Biotech CEOs and CSOs, IR and communications teams at clinical-stage companies, and agencies scaling coverage for life sciences clients. Agencies are among Featured's power users: the co-pilot handles opportunity discovery, drafting, and monitoring around the clock, so strategists can spend their time on messaging, relationships, and counsel.

Start with the recognized programs — Fierce Biotech's Fierce 15-style lists and industry innovation awards — plus conference showcases, then let Featured surface windows that fit your stage. For podcasts, Featured's database tracks 814,000 active shows; describe your science in plain language and it returns life sciences shows that actually book guests like you.